Fees-Exceed-the-Costs Waivers Under the Prescription Drug User Fee Act
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 1, 1999
March 15, 2019
635ddfab-1882-4949-ab8a-cbc7e467ad7f
Related Documents
Indexing Structured Product Labeling
Guidance DocumentJune 2, 2008Center for Drug Evaluation and Research
User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR
Guidance DocumentFebruary 8, 2007Center for Drug Evaluation and Research
E9 Statistical Principles for Clinical Trials
Guidance DocumentSeptember 16, 1998Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox